MARKET

CPRX

CPRX

Catalyst Pharmaceuticals Inc
NASDAQ
24.44
+0.53
+2.22%
After Hours: 24.35 -0.09 -0.37% 18:59 02/06 EST
OPEN
24.27
PREV CLOSE
23.91
HIGH
24.58
LOW
23.73
VOLUME
1.03M
TURNOVER
--
52 WEEK HIGH
26.58
52 WEEK LOW
19.05
MARKET CAP
3.00B
P/E (TTM)
14.26
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CPRX last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at CPRX last week (0119-0123)?
Weekly Report · 01/26 10:28
Catalyst Pharmaceuticals Inc. Stock Falls 3.6%, Underperforms Peers
Dow Jones · 01/23 21:34
Catalyst Pharmaceuticals: Rare-Disease Buy-and-Build Strategy, Strong Launches, and Capital Flexibility Underpin Buy Rating
TipRanks · 01/19 16:46
Weekly Report: what happened at CPRX last week (0112-0116)?
Weekly Report · 01/19 10:35
Jim Cramer: Crane Is A 'Good' Company, Recommends Holding This Tech Stock
Benzinga · 01/14 17:26
Catalyst Pharma Highlights Growth Strategy at J.P. Morgan Conference
TipRanks · 01/12 13:38
Weekly Report: what happened at CPRX last week (0105-0109)?
Weekly Report · 01/12 10:34
More
About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Webull offers Catalyst Pharmaceuticals Inc stock information, including NASDAQ: CPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPRX stock methods without spending real money on the virtual paper trading platform.